IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF

Inventiva S.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026

$2.98+0.04 (+1.36%)

Close on Oct 19, 2026

Inventiva S.A. revenue by segment

Inventiva does not break out revenue by segment, region or product in the tagged data of its filings for this period type.